What type of study is this?

This is a Systematic Review study (also classified as: Meta-Analysis).

September 12, 2025ERJ Open ResearchOpen Access

Effects of Salbutamol in Transient Tachypnoea of the Newborn: A Systematic Review and Meta-analysis

View Full Paper

Ask AI

Bookmark

Salbutamol significantly reduces hospital stay in newborns with transient tachypnoea by about 2.3 days.
Increased doses of salbutamol likely reduce oxygen therapy duration by nearly 19.4 hours.
Randomised-controlled trials highlighted the potential of salbutamol to decrease tachypnoea duration by approximately 6.6 hours.
The evidence for salbutamol's effects on mechanical ventilation needs remains very uncertain, stressing careful evaluation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Systematic review evaluates salbutamol's efficacy in reducing hospital stay and oxygen therapy in neonates with transient tachypnoea, suggesting modest benefits.

Cite This Study

Aznaran‐Torres et al. (2025) studied this question.

synapsesocial.com/papers/68d44a3731b076d99fa534bc https://doi.org/10.1183/23120541.00741-2025

View Full Paper

Ask AI

Bookmark

Implication

Systematic review evaluates salbutamol's efficacy in reducing hospital stay and oxygen therapy in neonates with transient tachypnoea, suggesting modest benefits.

Effects of Salbutamol in Transient Tachypnoea of the Newborn: A Systematic Review and Meta-analysis

Key Points

Discussion

Implication

Cite This Study

Effects of Salbutamol in Transient Tachypnoea of the Newborn: A Systematic Review and Meta-analysis

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider